The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Erythropoietin regulates tumour growth of human malignancies
Abstract
In addition to the chief function of erythropoietin (Epo) in promoting erythropoiesis, some other roles have been found in the brain and uterus. We have reported that signalling pathways of Epo and Epo receptor (EpoR) are involved in the tumourigenesis of ovarian and uterine cancers. To determine whether Epo plays a similar role in other malignancies, we studied the expression of Epo in several malignant human cell lines. We found that 24 malignant human cell lines examined express Epo and EpoR regardless of their origins, types, genetic characteristics and biological properties and secrete a very small amount of Epo individually and that most of them respond to hypoxic stimuli by enhanced secretion of Epo. To determine whether the Epo-EpoR pathway operates in tumours of these cell lines, we transplanted several cell lines into nude mice and confirmed the presence of Epo-responsive sites in xenografts in which the phosphorylation of the STAT5 (signal transducer and activator of transcription) is detectable. Furthermore, in nude mice we blocked the Epo signalling in xenografts of two representative cell lines, stomach choriocarcinoma and melanoma, by i.p. injections of EpoR antagonist and found inhibition of angiogenesis and survival of tumour cells leading to destruction of tumour masses and disturbances of phosphorylation of STAT5. In contrast, Epo mimetic peptide promotes angiogenesis and tumour cell survival. These findings suggest that Epo is indispensable for the growth and viability of malignant tumour and also that the deprivation of Epo signalling may be a promising therapy for human malignancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, ESA and RBC transfusions may have adverse immune-modulatory effects [126–129].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [128]
Citations
Cites
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617 · cited 3×
“Since Epo is a secreted protein (3,4) with hypoxia stimulating its secretion (22,23), and since tumours are hypoxic (29), we measured with an enzyme-linked assay (30) Epo protein in each culture medium under normoxia and anoxia.”
BackgroundMethodRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
(1999) · PubMed · Cited by 2,204
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579 · cited 1×
“Furthermore, studies of xenografts of ES cells with a loss of HIF-1α reveal attenuation of tumour growth and inhibition of angiogenesis (43,44); however, xenografts of ES cells with HIF-1α show tumour growth with abundant vascularity (43).”
BackgroundIhle, J. N. (1995) · Nature · doi:10.1038/377591a0 · Cited by 1,203 · cited 1×
“Binding Epo to its specific receptor (EpoR), which belongs to a family of cytokine receptors that have no tyrosine kinase domain, induces homodimerization of EpoR and the subsequent activation of a Janus kinase 2 (JAK2) through tyrosine phosphorylation, leading to activation of a transcriptional factor, STAT5 (signal…”
BackgroundBuettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,185
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172 · cited 2×
“Since Epo is a secreted protein (3,4) with hypoxia stimulating its secretion (22,23), and since tumours are hypoxic (29), we measured with an enzyme-linked assay (30) Epo protein in each culture medium under normoxia and anoxia.”
BackgroundMethodErythropoietin: structure, control of production, and function
Jelkmann, W. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.2.449 · Cited by 1,151
In vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949 · cited 1×
“Epo prevents ischaemia-induced and toxic-stressed death of neurons in vivo ( 19 ,20), and apoptotic neuronal death in the developing brain (21).”
BackgroundTumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858 · cited 2×
“Angiogenesis is essential for the development of malignant tumours: some angiogenesis inhibitors and inhibition of the Raf-1 gene expressed on capillary endothelium (38) suppress the proliferation of endothelial cells and lead to the regression of established tumours.”
Background
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
“Third, many malignant tumours express both erythropoietin and EPOR, and tumour growth is supported by erythropoietin both in vitro and in vivo”
BackgroundErythropoietin or darbepoetin for patients with cancer
Tonia, T., Mettler, A., Robert, N., Schwarzer, G., Seidenfeld, J., Weingart, O., Hyde, C., Engert, A., & Bohlius, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003407.pub5 · Cited by 392
Metadata
- Authors
- Yasuda, Y.
- Affiliations
- Kindai University (JP)
- Corresponding author
- Yasuda, Y.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-24
- Volume
- 24
- Issue
- 6
- Pages
- 1021-1029
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2102546064
- Cited by
- 257
- References
- 45
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 9 · 2016: 10 · 2015: 6 · 2014: 7 · 2013: 10 · 2012: 12
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- erythropoietin, erythropoietin receptor, tumor growth, STAT5 phosphorylation, hypoxia, angiogenesis, tumor cell survival, choriocarcinoma, melanoma, malignant cell lines, xenografts, anti-angiogenic therapy
- MeSH terms
- Cell Division, Erythropoietin, Humans, Neoplasms, Neovascularization, Pathologic, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Receptors, Erythropoietin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythropoietin regulates tumour growth of human malignancies. https://app.cochat.ai/papers/10.1093/carcin/bgg060
- The paper
- Yasuda, Y. (2003). Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. https://doi.org/10.1093/carcin/bgg060
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.